Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q96MU8
UPID:
KREM1_HUMAN
Alternative names:
Dickkopf receptor; Kringle domain-containing transmembrane protein 1; Kringle-containing protein marking the eye and the nose
Alternative UPACC:
Q96MU8; B0QY46; B0QY47; B1AJR5; Q5TIB9; Q6P3X6; Q9BY70; Q9UGS5; Q9UGU1
Background:
Kremen protein 1, also known as Dickkopf receptor, plays a pivotal role in the Wnt signaling pathway. It acts as a receptor for Dickkopf proteins, modulating Wnt/beta-catenin signaling through the endocytosis of Wnt receptors LRP5 and LRP6. This protein is crucial in limb development, bone formation, and cell fate decisions in the developing cochlea, showcasing its inhibitory role in hair cell fate specification.
Therapeutic significance:
Kremen protein 1's involvement in Ectodermal dysplasia 13, hair/tooth type, underscores its potential as a therapeutic target. Understanding the role of Kremen protein 1 could open doors to potential therapeutic strategies for treating abnormalities in hair, tooth development, and other ectodermal structures.